University of Texas Southwestern Medical Center Hematology and Medical Oncology

Topics

• Lung Cancer Treatments and Mutations 249
• Renal cell carcinoma treatment 210
• Acute Myeloid Leukemia Research 205
• Cancer Immunotherapy and Biomarkers 196
• Lung Cancer Research Studies 187
• Multiple Myeloma Research and Treatments 171
• HER2/EGFR in Cancer Research 137
• Chronic Lymphocytic Leukemia Research 133
• CAR-T cell therapy research 101
• Lung Cancer Diagnosis and Treatment 97
• PI3K/AKT/mTOR signaling in cancer 90
• Cancer Genomics and Diagnostics 89

Most cited

1. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Jonathan E. Dowell

2. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.

   The New England journal of medicine · 2021 · 2,130 citations · Larry Anderson

3. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Jonathan E. Dowell

4. Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.

   The New England journal of medicine · 2022 · 1,014 citations · Heather McArthur

5. PD-L1 as a biomarker of response to immune-checkpoint inhibitors.

   Nature reviews. Clinical oncology · 2021 · 1,282 citations · Sheena Bhalla

6. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.

   The New England journal of medicine · 2023 · 643 citations · Elizabeth Maher